Advantages of Ion Mobility for MALDI Imaging of N-glycans from Tumor Bearing FFPE Tissue in Clinical Research

Importance of the Topic

Protein glycosylation patterns serve as critical biomarkers in oncology. Imaging N-glycans directly from FFPE tissue maintains spatial context that is lost during homogenization, enabling correlation of glycan distributions with tumor microenvironments and disease progression.

Objectives and Study Overview

This study demonstrates the integration of ion mobility separation (IMS) into a MALDI MSI workflow to resolve isobaric N-glycan species directly from formalin-fixed paraffin-embedded colon cancer tissue. The aim is to map distinct glycan localizations in tumor versus adjacent non-tumor regions for enhanced clinical research insights.

Methods and Instrumentation

Tissue sections (5 µm) underwent deparaffinization, rehydration, and antigen retrieval. N-glycans were released in situ via on-slide PNGase F digestion, followed by application of α-cyano-4-hydroxycinnamic acid matrix. Analyses were conducted on a MALDI SYNAPT HDMS G2-Si instrument equipped with Triwave IMS in positive mode (m/z up to 3000) and 90 µm spatial resolution. Data processing and visualization employed Waters High Definition Imaging 1.4 software.

Main Results and Discussion

The overall mass spectrum displayed robust N-glycan signals, identifying 76 distinct glycans between m/z 771.5 and 2905.03. Incorporation of IMS introduced an orthogonal separation dimension, distinguishing a compact glycan trendline from slower-migrating matrix clusters. For example, the sodiated ion at m/z 1444.5 (Hex4dHex1HexNAc3) yielded two IMS-resolved peaks. Spatial ion images revealed one isomer enriched in tumor regions and the other predominantly in non-tumor areas, underscoring IMS’s capability for isomer-specific mapping.

Benefits and Practical Applications

• Enhanced specificity in N-glycan identification through separation of isobaric species
• Preservation of spatial distribution in FFPE samples for clinically relevant interpretations
• Seamless integration of IMS into existing MALDI MSI workflows without additional sample prep
• Improved potential for biomarker discovery and correlation with histopathology

Future Trends and Opportunities

Advancements in ion mobility resolution and accelerated imaging speeds will further refine isomer discrimination. Coupling IMS-MSI with complementary spatial omics and immunohistochemistry can deepen insights into tumor heterogeneity. Automation and high-throughput imaging may support routine clinical deployment.

Conclusion

Integrating ion mobility separation into MALDI imaging of N-glycans from FFPE tissue enhances molecular specificity and preserves spatial information essential for cancer research. This approach facilitates detailed isomer mapping, driving progress in biomarker identification and clinical diagnostics.

Reference

• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2013. National Cancer Institute; 2016.
• Powers TW, Drake RR, et al. MALDI Imaging Mass Spectrometry Profiling of N-glycans in FFPE Clinical Tissue Blocks. PLoS One. 2014;9(9):e106255.